Not Just for Kids: Spotlight on RSV in Older Adults

RSV is underdiagnosed in older adults, and future vaccines may reduce its burden in this population. Here are my thoughts on RSV vaccine development and where the vaccines may fit in the current immunization schedule.

Laura Hurley, MD, MPH Released: September 19, 2022

An RSV vaccine, if approved, may reduce disease burden in older adults. Here are our ideas on overcoming barriers to the implementation of vaccines for older adults in primary care settings.

John J. Russell, MD, FAAFP
Program Director Laura Hurley, MD, MPH Pamela Rockwell, DO, FAAFP Released: October 17, 2022

Want to learn more about RSV vaccines? Read my commentary about the latest data presented at the IDWeek 2022 meeting.

Pamela Rockwell, DO, FAAFP Released: December 23, 2022